Star award against gradient background with the Allergy & Asthma Network logo

Allergy & Asthma Network is grateful to earn recognition for its leadership and commitment to health equity. The organization and its partners were recently honored in three national award programs:

The Network continues to prioritize health equity, diversity and inclusion. It is prominent in all four of the organization’s mission areas. Since 2020, the Network initiated and expanded several programs to better meet the healthcare needs of Black, Hispanic/Latino and Native Americans. These groups are particularly impacted by disparities in asthma, COPD and COVID-19 care. They face higher rates of hospitalization and death from these conditions.

The Network’s programs address barriers to care, including social and economic factors. They seek to improve health equity by raising awareness and expanding access to care in these underserved communities.

The three national awards follow two Patient-Centered Outcomes Research Institute (PCORI) Engagement Awards the Network received in 2020-21. The Engagement Awards were focused on health equity. The Network hosted the Black People Like Me and Unidos Hablemos virtual conference series funded through the awards. The series focused on engaging Black and Hispanic/Latino patients in research.

awards the Network received in 2022

Learn more about the three national awards:

PR News 2022 Social Impact Award – Honorable Mention, Not One More Life Trusted Messengers

The innovative Not One More Life Trusted Messengers program was named a finalist for a PR News 2022 Social Impact Award in the “Corporate-Community Partnership” category. The program earned Honorable Mention at the Social Impact Awards Luncheon on April 20.

Not One More Life Trusted Messengers was developed by Allergy & Asthma Network. It is made possible through donations from Sanofi US and other corporate partners.

The Social Impact Awards honor communicators who use their platforms to better their community and the global community at large. Winners are the campaigns, initiatives, professionals, teams, rising stars and lifetime pioneers that are helping to usher in a diverse, equitable future and redefine organizations’ role in the fight for global change.

Allergy & Asthma Network, ACAAI Named Finalists for Ragan Communications and PR Daily CSR & Diversity Awards

Allergy & Asthma Network and ACAAI were named finalists for Ragan’s CSR & Diversity Awards for the EczemaInSkinofColor.org website. The organizations were nominated in the “Industry Partnerships/Alliances” category. Category winners will be announced on July 14 at a special event in New York City.

The Network and ACAAI partnered to create EczemaInSkinofColor.org. The site is an online resource that examines the unique challenges in diagnosing eczema in people of color. It is also a visual aid to show what eczema looks like in people with all skin types. Familiarity with what eczema looks like in skin of color is essential to making a correct diagnosis and creating a treatment plan.

Ragan Communications CSR (Corporations for Social Responsibility) & Diversity Awards celebrates changemakers and their commitment to improving their communities.

Allergy & Asthma Network Recognized as Changemaker, Named Awardee in Johnson & Johnson Health Equity Innovation Challenge

Allergy & Asthma Network was recently named an awardee in the Health Equity Innovation Challenge from Johnson & Johnson. Selected from a pool of over 180 applications, we proudly join 13 other changemakers working to generate solutions to help close racial health and mortality gaps in six cities where Black and Brown communities experience significant health inequities: Chicago, Detroit, Los Angeles, New Orleans, New York City and Philadelphia.

Allergy & Asthma Network was awarded for its innovative Not One More Life Trusted Messengers program , which sends physicians, nurses and educators to places of worship to mitigate the impact of COVID-19, asthma, and COPD in Black and Latinx communities. Funds from the Johnson & Johnson Health Equity Innovation Challenge will be used to expand our successful program through live events and educational materials. The disproportionate impact of COVID-19 on these communities has been astounding. According to the City of Chicago, 29% of those diagnosed with COVID-19 are Latinx people, while 22.3% are Black people. Staggering numbers when considered that each of these communities make up 30% of Chicago’s population respectively.

As one of 14 awardees nationwide, the Allergy & Asthma Network is receiving seed funding totaling $75,000, mentorship from renowned entrepreneurs and public health experts, and access to the Johnson & Johnson – JLABS ecosystem, which includes networking opportunities and more, to advance our efforts.

The Health Equity Innovation Challenge was created by Johnson & Johnson with the ambition to foster innovation, entrepreneurship and socioeconomic impact by accelerating innovative solutions from local entrepreneurs, innovators and community-based organizations that have the potential to advance health equity.